Dental care can be expensive. But nearly half of Medicare beneficiaries don’t have dental coverage, according to KFF[1].
RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...
Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...
Jefferies analyst David Stanton upgraded Cochlear Ltd. shares from Hold to Buy, adjusting the price target slightly upward from AUD305.00 to AUD308.00. The upgrade comes as the $10.91 billion market ...
The former glamour model, 45, has gone under the knife for a long list of procedures, most recently jetting to Turkey to have ...
The Cochlear Ltd (ASX: COH) share price is sinking on Friday after the hearing solutions company's half year result ...
Paradromics Inc., a brain implant rival to Elon Musk’s Neuralink Corp., is partnering with Saudi Arabia’s Neom to develop brain-computer interface therapies in the Middle East and North Africa.